A video rundown of what Eli Lilly's late-stage retatrutide trial data shows for people following the drug.
Recap by typeshit. Full story at On The Pen™ GLP-1 News.
The Scientist weighs whether GLP-1 drugs could lengthen life and finds the answer still unsettled. Tap through for where the research stands.
The review covers 47 peptides from meat, leather and seafood waste and cites a 12-trial meta-analysis showing a systolic drop of about 5 mmHg, credited to the authors.
Researchers think orexin drugs could expand into ADHD and fatigue the way GLP-1s grew past diabetes. Alkermes reported early ADHD results in 50 adults.
Researchers report in Amino Acids that the peptide blocks HMGA2 at the IL6 promoter in a cell model. The authors note the work is cell culture only, far from any human use.
The pharmacy trade group plans to show how pharmacists help GLP-1 patients stay on track. Drug Store News has the event details.
A Nara team found the SglPP7 tail locks MurJ open, a different route than the unrelated phage protein LysM uses to hit the same cell wall target.
Loading…